FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 333:294-296 August 3, 1995 Number 5 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Arenaviruses are a group of RNA viruses several of which have the potential to cause a deadly syndrome of hemorrhagic fever. In humans these viruses are usually transmitted by exposure to infected rodent excreta; occasional laboratory or nosocomial infections have been reported.¹ Sabiá virus is an arenavirus that was first isolated in São Paulo, Brazil, in 1990 from an agricultural engineer who presented with a hemorrhagic fever syndrome and ultimately died. Necrosis of the liver was found at autopsy. The virus was subsequently characterized as a new member of the Tacaribe complex of the family Arenaviridae.² A laboratory technician in . . . [Full Text of this Article]

Case Report

Occupational Exposure

Case Presentation and Clinical Course

Biosafety Management and Contact Surveillance

Discussion

Source Information

From the Department of Internal Medicine (M.B., M.R., D.G., L.D.) and Yale Arbovirus Research Unit, Department of Epidemiology and Public Health (R.T.), Yale University School of Medicine, New Haven, Conn.; the Special Pathogens Branch, Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta (L.A., A.S.K., C.J.P.); and Institut Français de Recherche Scientifique pour le Développement en Coopération, Paris (J.P.G.).

Address reprint requests to Dr. Barry at the International Health Program, Yale University School of Medicine, 20 York St., New Haven, CT 06504.

References

This article has been cited by other articles:

• Larson, R. A., Dai, D., Hosack, V. T., Tan, Y., Bolken, T. C., Hruby, D. E., Amberg, S. M. (2008). Identification of a Broad-Spectrum Arenavirus Entry Inhibitor. J. Virol. 82: 10768-10775 [Abstract] [Full Text]  
• Kimman, T. G., Smit, E., Klein, M. R. (2008). Evidence-Based Biosafety: a Review of the Principles and Effectiveness of Microbiological Containment Measures. Clin. Microbiol. Rev. 21: 403-425 [Abstract] [Full Text]  
• SBRANA, E., XIAO, S.-Y., GUZMAN, H., YE, M., TRAVASSOS DA ROSA, A. P. A., TESH, R. B. (2004). EFFICACY OF POST-EXPOSURE TREATMENT OF YELLOW FEVER WITH RIBAVIRIN IN A HAMSTER MODEL OF THE DISEASE. Am J Trop Med Hyg 71: 306-312 [Abstract] [Full Text]  
• Gavin, P. J., Katz, B. Z. (2002). Intravenous Ribavirin Treatment for Severe Adenovirus Disease in Immunocompromised Children. Pediatrics 110: e9-9 [Abstract] [Full Text]  
• Murphy, F. A., Johnson, K. M. (1995). An Exotic Viral Disease Acquired in a Laboratory. NEJM 333: 317-319 [Full Text]